RxDoctor Payments Data

Chijioke Ikomi

Pediatrics · Wilmington, DENPI 1972940989

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.

$239in general payments, 2019–2025

Across 11 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$38
  • AbbVie$34
  • Medtronic$32
  • Neurocrine Biosciences, Inc.$26
  • Sanofi-aventis U.S. LLC$26
  • Pfizer$22
  • plus $61 from 3 others
$567,026in research payments, 2019–2025

Across 345 payments — averaging $1643.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$263K
  • Novo Nordisk AS$240K
  • Biomarin Pharmaceutical Inc.$63K
  • Novo Nordisk$1K

What the payments were for

  • Food & beverage$239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$239 in reported general payments places this provider in the 55th percentile of 184 pediatrics providers in Delaware.

See all pediatrics providers in Delaware

Other pediatrics in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →